In summary, five diagnostic biomarkers (HSPA5, HSP90B1, DNAJC3, PDIA6, and HERPUD1) were identified in EMs, providing new perspectives for the diagnosis, mechanism, investigation, and management of EMs. Here, DNAJC3 is linked to eosinophilia-myalgia syndrome.